Enzyme Office Spaces Signs 10-Year Lease for Large Bengaluru Expansion

Enzyme Office Spaces has made a substantial bet on Bengaluru’s office market, securing nearly 3.4 lakh square feet across three key business districts. The leases, finalized between mid-February and early March, will cost the firm about ₹2.5 crore in monthly rent over a ten-year term.

The largest share of this expansion is located in Whitefield, where Enzyme has taken roughly 1.8 lakh square feet. Another 1.5 lakh square feet has been secured in HSR Layout, a locality long favored by startups, while a smaller 16,000 square foot facility has been added in Hebbal. The Hebbal center forms part of the larger Umiya Velocity development.

Both of these sites are being converted into managed office spaces with a combined capacity of around 5,000 seats. Once operational, Enzyme’s nationwide footprint will rise to approximately 60,000 seats, reinforcing its position in a segment that continues to attract both early-stage ventures and multinational firms.

The company’s model is straightforward but capital-intensive. It leases large properties, invests in fit-outs and infrastructure, and then offers them as ready-to-use offices. This approach allows clients to scale quickly without the burden of long-term real estate commitments. According to the company, the HSR center will primarily cater to startups, while the Whitefield and Hebbal locations are being positioned for global capability centers, which remain a strong source of demand in Bengaluru.

Timelines for the rollout are tight. The HSR property is expected to be ready within three months, while the Hebbal site should be handed over by April. Work is already underway to modify the Whitefield building to suit enterprise clients.

Enzyme is also looking ahead. It plans to add another 2 to 2.5 lakh square feet in the coming financial year, aiming to capitalize on rising interest in flexible workspaces. With an existing portfolio of 2 million square feet and clients such as Paytm, the company is targeting ₹50 crore in annual revenue next year, reflecting confidence in a market that continues to evolve rather than contract.